Prediction Case File
YouTubeTracking Live

$25,175 in IBM Stock vs. One $685 Put. Same Risk.

1 extracted signal · 0 resolved · 1 still active

tastylive profile imagetastyliveIndependent analyst profile
Source published
27 Oct 2026, 02:00 UTC
Recorded by Tahlil Plus
27 Oct 2026, 03:23 UTC
Video preview for $25,175 in IBM Stock vs. One $685 Put. Same Risk.
Source overview

AI-generated source summary

The analysis focuses on comparing the strategy of buying 100 shares of IBM at $251.61 with selling one IBM put option with a strike price of $245 and a credit of $6.85 per share. The maximum loss for buying the stock outright is approximately $25,000, while selling the put limits the maximum loss to around $23,815, suggesting a slightly lower risk profile for the short put strategy. If the stock price stays above the $245 strike at expiration, the put seller keeps the $685 credit. If the stock price rises 20% annually, buying the stock yields a profit of $5,000 over a year, while selling 12 monthly puts at $680 each yields $8,160 in premiums, representing a 32.6% stock gain to match the premiums. However, a single loss on a short put can negate several months of gains. The net cost per share if assigned on the short put would be $238.15 ($245 strike - $6.85 credit). The analysis suggests that if one anticipates a significant rally in IBM, buying the stock might be more profitable, whereas a more modest rally or sideways movement would favor selling the put due to the premium collected and theta decay. The analysis highlights the capital efficiency of selling a put compared to buying stock, as it only requires margin rather than the full share price.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

tastylive

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
18
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail